Cita NeuroPharmaceuticals Report issue

For profit Phase 2
Founded: Mississauga ON Canada (1997)
Status: Acquired by Vernalis (2005) → now HitGen Inc. (2020)

Organization Overview

First Clinical Trial
2006
NCT00375960
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (3)

entacapone (comtan) (1 trial)

indantadol (1 trial)

melevodopa (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 2)

Neuralgia (Phase 2)

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3